In conclusion, our study reveals the potential role of IRF5 derived from M1‐like macrophage exosomes in lung cancer treatment through the upregulation of HLA‐E expression, thus providing a novel theoretical foundation for future immunotherapy strategies. This evidence concerns the gene IRF5 and lung carcinoma.